Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT04046029

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04046029
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04046029. Randomized; single masking; primary purpose treatment. Start 2019-07-08 (actual); primary completion 2020-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
Condition
Acute Coronary Syndrome
Condition
Aging
Condition
Anticoagulants and Bleeding Disorders
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Heparin
Lead sponsor
The First Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
Beijing Friendship Hospital (class: other)

Record details

Record id
cardio:ct-nct04046029
Content hash
8b6fd3558939c668048c06deabade403d0aa945fae80a371f6b6f77b4f4ebc4f